levofloxacin claris 5 mg/ml šķīdums infūzijām
claris lifesciences (uk) limited, united kingdom - levofloksacīns - Šķīdums infūzijām - 5 mg/ml
plavix
sanofi winthrop industrie - klopidogrela ūdeņraža sulfāts - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - antitrombotiskie līdzekļi - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. profilakse atherothrombotic un trombembolisku notikumu ātriju fibrillationin pieaugušiem pacientiem ar priekškambaru mirdzēšana, kuriem ir vismaz viena riska faktors asinsvadu notikumi, nav piemēroti apstrādei ar vitamīna k antagonisti un, kas ir zems asiņošanas risku, klopidogrelu, ir norādīts kopā ar asa novēršanas atherothrombotic un trombembolisku notikumu, tostarp insulta.
iplaceh pilieni iekšķīgai lietošanai, šķidrums
uab bayer, lithuania - carvi fructus extractum fluidum, iberis amarae extractum fluidum, melissae folii extractum fluidum, liquiritiae radicis extractum fluidum, matricariae extractum fluidum, menthae piperitae folii extractum fluidum - pilieni iekšķīgai lietošanai, šķidrums
clariscan 0,5 mmol/ml šķīdums injekcijām
ge healthcare as, norway - gadoterskābe - Šķīdums injekcijām - 0,5 mmol/ml
clariscan 0,5 mmol/ml šķīdums injekcijām pilnšļircē
ge healthcare as, norway - gadoterskābe - Šķīdums injekcijām pilnšļircē - 0,5 mmol/ml
larixc arg sibīrijas lapegles arabinogalaktāns (2020.) pulveris
medpro nutraceuticals sia - pulveris
larix + c (paziņots 2015.) kapsula
medpro nutraceuticals sia - kapsula
larixc taxifolin (2017.) pulveris
medpro nutraceuticals sia - pulveris
anti-dispepsia tabletes
pharmaceutical laboratory labofarm, poland - taraxaci officinalis saknes, carvi augļu, menthae piperitae lapu, condurango garozā, silybi mariani ekstrakts sausai raffinatum un standartizētas - tablete
iberogast šķidrums iekšķīgai lietošanai
uab bayer, lithuania - iberis rūgta ekstrakts, angelicae saknes, matricariae ziedu, carvi augļu silybi mariani augļu, melissae lapu, menthae piperitae lapu, chelidonii augu, lakrica sakne - Šķidrums iekšķīgai lietošanai